Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Long-acting Injectable Medications Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 First-generation
1.2.3 Second-generation
1.3 Market by Application
1.3.1 Global Long-acting Injectable Medications Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Schizophrenia
1.3.3 Contraception
1.3.4 HIV
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Long-acting Injectable Medications Market Perspective (2018-2033)
2.2 Long-acting Injectable Medications Growth Trends by Region
2.2.1 Global Long-acting Injectable Medications Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Long-acting Injectable Medications Historic Market Size by Region (2018-2023)
2.2.3 Long-acting Injectable Medications Forecasted Market Size by Region (2024-2033)
2.3 Long-acting Injectable Medications Market Dynamics
2.3.1 Long-acting Injectable Medications Industry Trends
2.3.2 Long-acting Injectable Medications Market Drivers
2.3.3 Long-acting Injectable Medications Market Challenges
2.3.4 Long-acting Injectable Medications Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Long-acting Injectable Medications Players by Revenue
3.1.1 Global Top Long-acting Injectable Medications Players by Revenue (2018-2023)
3.1.2 Global Long-acting Injectable Medications Revenue Market Share by Players (2018-2023)
3.2 Global Long-acting Injectable Medications Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Long-acting Injectable Medications Revenue
3.4 Global Long-acting Injectable Medications Market Concentration Ratio
3.4.1 Global Long-acting Injectable Medications Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Long-acting Injectable Medications Revenue in 2022
3.5 Long-acting Injectable Medications Key Players Head office and Area Served
3.6 Key Players Long-acting Injectable Medications Product Solution and Service
3.7 Date of Enter into Long-acting Injectable Medications Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Long-acting Injectable Medications Breakdown Data by Type
4.1 Global Long-acting Injectable Medications Historic Market Size by Type (2018-2023)
4.2 Global Long-acting Injectable Medications Forecasted Market Size by Type (2024-2033)
5 Long-acting Injectable Medications Breakdown Data by Application
5.1 Global Long-acting Injectable Medications Historic Market Size by Application (2018-2023)
5.2 Global Long-acting Injectable Medications Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Long-acting Injectable Medications Market Size (2018-2033)
6.2 North America Long-acting Injectable Medications Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Long-acting Injectable Medications Market Size by Country (2018-2023)
6.4 North America Long-acting Injectable Medications Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Long-acting Injectable Medications Market Size (2018-2033)
7.2 Europe Long-acting Injectable Medications Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Long-acting Injectable Medications Market Size by Country (2018-2023)
7.4 Europe Long-acting Injectable Medications Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Long-acting Injectable Medications Market Size (2018-2033)
8.2 Asia-Pacific Long-acting Injectable Medications Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Long-acting Injectable Medications Market Size by Region (2018-2023)
8.4 Asia-Pacific Long-acting Injectable Medications Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Long-acting Injectable Medications Market Size (2018-2033)
9.2 Latin America Long-acting Injectable Medications Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Long-acting Injectable Medications Market Size by Country (2018-2023)
9.4 Latin America Long-acting Injectable Medications Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Long-acting Injectable Medications Market Size (2018-2033)
10.2 Middle East & Africa Long-acting Injectable Medications Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Long-acting Injectable Medications Market Size by Country (2018-2023)
10.4 Middle East & Africa Long-acting Injectable Medications Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Eli Lilly
11.1.1 Eli Lilly Company Detail
11.1.2 Eli Lilly Business Overview
11.1.3 Eli Lilly Long-acting Injectable Medications Introduction
11.1.4 Eli Lilly Revenue in Long-acting Injectable Medications Business (2018-2023)
11.1.5 Eli Lilly Recent Development
11.2 Alkermes
11.2.1 Alkermes Company Detail
11.2.2 Alkermes Business Overview
11.2.3 Alkermes Long-acting Injectable Medications Introduction
11.2.4 Alkermes Revenue in Long-acting Injectable Medications Business (2018-2023)
11.2.5 Alkermes Recent Development
11.3 Johnson & Johnson
11.3.1 Johnson & Johnson Company Detail
11.3.2 Johnson & Johnson Business Overview
11.3.3 Johnson & Johnson Long-acting Injectable Medications Introduction
11.3.4 Johnson & Johnson Revenue in Long-acting Injectable Medications Business (2018-2023)
11.3.5 Johnson & Johnson Recent Development
11.4 Zogenix
11.4.1 Zogenix Company Detail
11.4.2 Zogenix Business Overview
11.4.3 Zogenix Long-acting Injectable Medications Introduction
11.4.4 Zogenix Revenue in Long-acting Injectable Medications Business (2018-2023)
11.4.5 Zogenix Recent Development
11.5 DURECT
11.5.1 DURECT Company Detail
11.5.2 DURECT Business Overview
11.5.3 DURECT Long-acting Injectable Medications Introduction
11.5.4 DURECT Revenue in Long-acting Injectable Medications Business (2018-2023)
11.5.5 DURECT Recent Development
11.6 Mapi Pharma
11.6.1 Mapi Pharma Company Detail
11.6.2 Mapi Pharma Business Overview
11.6.3 Mapi Pharma Long-acting Injectable Medications Introduction
11.6.4 Mapi Pharma Revenue in Long-acting Injectable Medications Business (2018-2023)
11.6.5 Mapi Pharma Recent Development
11.7 GSK
11.7.1 GSK Company Detail
11.7.2 GSK Business Overview
11.7.3 GSK Long-acting Injectable Medications Introduction
11.7.4 GSK Revenue in Long-acting Injectable Medications Business (2018-2023)
11.7.5 GSK Recent Development
11.8 MedinCell
11.8.1 MedinCell Company Detail
11.8.2 MedinCell Business Overview
11.8.3 MedinCell Long-acting Injectable Medications Introduction
11.8.4 MedinCell Revenue in Long-acting Injectable Medications Business (2018-2023)
11.8.5 MedinCell Recent Development
11.9 Oakwood Labs
11.9.1 Oakwood Labs Company Detail
11.9.2 Oakwood Labs Business Overview
11.9.3 Oakwood Labs Long-acting Injectable Medications Introduction
11.9.4 Oakwood Labs Revenue in Long-acting Injectable Medications Business (2018-2023)
11.9.5 Oakwood Labs Recent Development
11.10 Nanomi
11.10.1 Nanomi Company Detail
11.10.2 Nanomi Business Overview
11.10.3 Nanomi Long-acting Injectable Medications Introduction
11.10.4 Nanomi Revenue in Long-acting Injectable Medications Business (2018-2023)
11.10.5 Nanomi Recent Development
11.11 Pharmathen
11.11.1 Pharmathen Company Detail
11.11.2 Pharmathen Business Overview
11.11.3 Pharmathen Long-acting Injectable Medications Introduction
11.11.4 Pharmathen Revenue in Long-acting Injectable Medications Business (2018-2023)
11.11.5 Pharmathen Recent Development
11.12 Kashiv BioSciences
11.12.1 Kashiv BioSciences Company Detail
11.12.2 Kashiv BioSciences Business Overview
11.12.3 Kashiv BioSciences Long-acting Injectable Medications Introduction
11.12.4 Kashiv BioSciences Revenue in Long-acting Injectable Medications Business (2018-2023)
11.12.5 Kashiv BioSciences Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Long-acting Injectable Medications Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of First-generation
Table 3. Key Players of Second-generation
Table 4. Global Long-acting Injectable Medications Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 5. Global Long-acting Injectable Medications Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 6. Global Long-acting Injectable Medications Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Long-acting Injectable Medications Market Share by Region (2018-2023)
Table 8. Global Long-acting Injectable Medications Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 9. Global Long-acting Injectable Medications Market Share by Region (2024-2033)
Table 10. Long-acting Injectable Medications Market Trends
Table 11. Long-acting Injectable Medications Market Drivers
Table 12. Long-acting Injectable Medications Market Challenges
Table 13. Long-acting Injectable Medications Market Restraints
Table 14. Global Long-acting Injectable Medications Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Long-acting Injectable Medications Market Share by Players (2018-2023)
Table 16. Global Top Long-acting Injectable Medications Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Long-acting Injectable Medications as of 2022)
Table 17. Ranking of Global Top Long-acting Injectable Medications Companies by Revenue (US$ Million) in 2022
Table 18. Global 5 Largest Players Market Share by Long-acting Injectable Medications Revenue (CR5 and HHI) & (2018-2023)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Long-acting Injectable Medications Product Solution and Service
Table 21. Date of Enter into Long-acting Injectable Medications Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Long-acting Injectable Medications Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Long-acting Injectable Medications Revenue Market Share by Type (2018-2023)
Table 25. Global Long-acting Injectable Medications Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 26. Global Long-acting Injectable Medications Revenue Market Share by Type (2024-2033)
Table 27. Global Long-acting Injectable Medications Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Long-acting Injectable Medications Revenue Market Share by Application (2018-2023)
Table 29. Global Long-acting Injectable Medications Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 30. Global Long-acting Injectable Medications Revenue Market Share by Application (2024-2033)
Table 31. North America Long-acting Injectable Medications Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 32. North America Long-acting Injectable Medications Market Size by Country (2018-2023) & (US$ Million)
Table 33. North America Long-acting Injectable Medications Market Size by Country (2024-2033) & (US$ Million)
Table 34. Europe Long-acting Injectable Medications Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 35. Europe Long-acting Injectable Medications Market Size by Country (2018-2023) & (US$ Million)
Table 36. Europe Long-acting Injectable Medications Market Size by Country (2024-2033) & (US$ Million)
Table 37. Asia-Pacific Long-acting Injectable Medications Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 38. Asia-Pacific Long-acting Injectable Medications Market Size by Region (2018-2023) & (US$ Million)
Table 39. Asia-Pacific Long-acting Injectable Medications Market Size by Region (2024-2033) & (US$ Million)
Table 40. Latin America Long-acting Injectable Medications Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 41. Latin America Long-acting Injectable Medications Market Size by Country (2018-2023) & (US$ Million)
Table 42. Latin America Long-acting Injectable Medications Market Size by Country (2024-2033) & (US$ Million)
Table 43. Middle East & Africa Long-acting Injectable Medications Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 44. Middle East & Africa Long-acting Injectable Medications Market Size by Country (2018-2023) & (US$ Million)
Table 45. Middle East & Africa Long-acting Injectable Medications Market Size by Country (2024-2033) & (US$ Million)
Table 46. Eli Lilly Company Detail
Table 47. Eli Lilly Business Overview
Table 48. Eli Lilly Long-acting Injectable Medications Product
Table 49. Eli Lilly Revenue in Long-acting Injectable Medications Business (2018-2023) & (US$ Million)
Table 50. Eli Lilly Recent Development
Table 51. Alkermes Company Detail
Table 52. Alkermes Business Overview
Table 53. Alkermes Long-acting Injectable Medications Product
Table 54. Alkermes Revenue in Long-acting Injectable Medications Business (2018-2023) & (US$ Million)
Table 55. Alkermes Recent Development
Table 56. Johnson & Johnson Company Detail
Table 57. Johnson & Johnson Business Overview
Table 58. Johnson & Johnson Long-acting Injectable Medications Product
Table 59. Johnson & Johnson Revenue in Long-acting Injectable Medications Business (2018-2023) & (US$ Million)
Table 60. Johnson & Johnson Recent Development
Table 61. Zogenix Company Detail
Table 62. Zogenix Business Overview
Table 63. Zogenix Long-acting Injectable Medications Product
Table 64. Zogenix Revenue in Long-acting Injectable Medications Business (2018-2023) & (US$ Million)
Table 65. Zogenix Recent Development
Table 66. DURECT Company Detail
Table 67. DURECT Business Overview
Table 68. DURECT Long-acting Injectable Medications Product
Table 69. DURECT Revenue in Long-acting Injectable Medications Business (2018-2023) & (US$ Million)
Table 70. DURECT Recent Development
Table 71. Mapi Pharma Company Detail
Table 72. Mapi Pharma Business Overview
Table 73. Mapi Pharma Long-acting Injectable Medications Product
Table 74. Mapi Pharma Revenue in Long-acting Injectable Medications Business (2018-2023) & (US$ Million)
Table 75. Mapi Pharma Recent Development
Table 76. GSK Company Detail
Table 77. GSK Business Overview
Table 78. GSK Long-acting Injectable Medications Product
Table 79. GSK Revenue in Long-acting Injectable Medications Business (2018-2023) & (US$ Million)
Table 80. GSK Recent Development
Table 81. MedinCell Company Detail
Table 82. MedinCell Business Overview
Table 83. MedinCell Long-acting Injectable Medications Product
Table 84. MedinCell Revenue in Long-acting Injectable Medications Business (2018-2023) & (US$ Million)
Table 85. MedinCell Recent Development
Table 86. Oakwood Labs Company Detail
Table 87. Oakwood Labs Business Overview
Table 88. Oakwood Labs Long-acting Injectable Medications Product
Table 89. Oakwood Labs Revenue in Long-acting Injectable Medications Business (2018-2023) & (US$ Million)
Table 90. Oakwood Labs Recent Development
Table 91. Nanomi Company Detail
Table 92. Nanomi Business Overview
Table 93. Nanomi Long-acting Injectable Medications Product
Table 94. Nanomi Revenue in Long-acting Injectable Medications Business (2018-2023) & (US$ Million)
Table 95. Nanomi Recent Development
Table 96. Pharmathen Company Detail
Table 97. Pharmathen Business Overview
Table 98. Pharmathen Long-acting Injectable Medications Product
Table 99. Pharmathen Revenue in Long-acting Injectable Medications Business (2018-2023) & (US$ Million)
Table 100. Pharmathen Recent Development
Table 101. Kashiv BioSciences Company Detail
Table 102. Kashiv BioSciences Business Overview
Table 103. Kashiv BioSciences Long-acting Injectable Medications Product
Table 104. Kashiv BioSciences Revenue in Long-acting Injectable Medications Business (2018-2023) & (US$ Million)
Table 105. Kashiv BioSciences Recent Development
Table 106. Research Programs/Design for This Report
Table 107. Key Data Information from Secondary Sources
Table 108. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Long-acting Injectable Medications Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Long-acting Injectable Medications Market Share by Type: 2022 VS 2033
Figure 3. First-generation Features
Figure 4. Second-generation Features
Figure 5. Global Long-acting Injectable Medications Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 6. Global Long-acting Injectable Medications Market Share by Application: 2022 VS 2033
Figure 7. Schizophrenia Case Studies
Figure 8. Contraception Case Studies
Figure 9. HIV Case Studies
Figure 10. Others Case Studies
Figure 11. Long-acting Injectable Medications Report Years Considered
Figure 12. Global Long-acting Injectable Medications Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 13. Global Long-acting Injectable Medications Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 14. Global Long-acting Injectable Medications Market Share by Region: 2022 VS 2033
Figure 15. Global Long-acting Injectable Medications Market Share by Players in 2022
Figure 16. Global Top Long-acting Injectable Medications Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Long-acting Injectable Medications as of 2022)
Figure 17. The Top 10 and 5 Players Market Share by Long-acting Injectable Medications Revenue in 2022
Figure 18. North America Long-acting Injectable Medications Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 19. North America Long-acting Injectable Medications Market Share by Country (2018-2033)
Figure 20. United States Long-acting Injectable Medications Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 21. Canada Long-acting Injectable Medications Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. Europe Long-acting Injectable Medications Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. Europe Long-acting Injectable Medications Market Share by Country (2018-2033)
Figure 24. Germany Long-acting Injectable Medications Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. France Long-acting Injectable Medications Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. U.K. Long-acting Injectable Medications Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. Italy Long-acting Injectable Medications Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. Russia Long-acting Injectable Medications Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Nordic Countries Long-acting Injectable Medications Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Asia-Pacific Long-acting Injectable Medications Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Asia-Pacific Long-acting Injectable Medications Market Share by Region (2018-2033)
Figure 32. China Long-acting Injectable Medications Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Japan Long-acting Injectable Medications Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. South Korea Long-acting Injectable Medications Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. Southeast Asia Long-acting Injectable Medications Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. India Long-acting Injectable Medications Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. Australia Long-acting Injectable Medications Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. Latin America Long-acting Injectable Medications Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. Latin America Long-acting Injectable Medications Market Share by Country (2018-2033)
Figure 40. Mexico Long-acting Injectable Medications Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Brazil Long-acting Injectable Medications Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. Middle East & Africa Long-acting Injectable Medications Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Middle East & Africa Long-acting Injectable Medications Market Share by Country (2018-2033)
Figure 44. Turkey Long-acting Injectable Medications Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Saudi Arabia Long-acting Injectable Medications Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. Eli Lilly Revenue Growth Rate in Long-acting Injectable Medications Business (2018-2023)
Figure 47. Alkermes Revenue Growth Rate in Long-acting Injectable Medications Business (2018-2023)
Figure 48. Johnson & Johnson Revenue Growth Rate in Long-acting Injectable Medications Business (2018-2023)
Figure 49. Zogenix Revenue Growth Rate in Long-acting Injectable Medications Business (2018-2023)
Figure 50. DURECT Revenue Growth Rate in Long-acting Injectable Medications Business (2018-2023)
Figure 51. Mapi Pharma Revenue Growth Rate in Long-acting Injectable Medications Business (2018-2023)
Figure 52. GSK Revenue Growth Rate in Long-acting Injectable Medications Business (2018-2023)
Figure 53. MedinCell Revenue Growth Rate in Long-acting Injectable Medications Business (2018-2023)
Figure 54. Oakwood Labs Revenue Growth Rate in Long-acting Injectable Medications Business (2018-2023)
Figure 55. Nanomi Revenue Growth Rate in Long-acting Injectable Medications Business (2018-2023)
Figure 56. Pharmathen Revenue Growth Rate in Long-acting Injectable Medications Business (2018-2023)
Figure 57. Kashiv BioSciences Revenue Growth Rate in Long-acting Injectable Medications Business (2018-2023)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed